InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Maze Therapeutics, Inc.

MAZE Clue Score57
United States Fiscal year ends December CIK 0001842295 Results filed 11 Aug 2026
Add to watchlist

What the insiders did Mostly scheduled

Individual transactions

60
Insider
Date
Role
Action
Shares
Price
Amount
Atul Dandekar
29 Oct 2026
Csbo
Sold after exercise
7,500
$32.07
$240.53K
Harold Bernstein
1 Oct 2026
President, R&D & CMO
Sold after exercise
16,141
$26.93
$434.74K
Atul Dandekar
29 Sep 2026
Csbo
Sold after exercise
7,500
$27.06
$202.92K
Harold Bernstein
1 Sep 2026
President, R&D & CMO
Sold after exercise
16,141
$26.36
$425.51K
Jason Coloma V
1 Sep 2026
Chief Executive Officer
Sold after exercise indirect
31,908
$26.29
$838.78K
Jason Coloma V
1 Sep 2026
Chief Executive Officer
Sold after exercise indirect
2,593
$26.31
$68.21K
Atul Dandekar
28 Aug 2026
Csbo
Sold after exercise
7,500
$27.58
$206.82K
Harold Bernstein
13 Aug 2026
President, R&D & CMO
Sold after exercise
16,142
$27.61
$445.62K
Atul Dandekar
29 Jul 2026
Csbo
Sold after exercise
400
$27.89
$11.16K
Atul Dandekar
29 Jul 2026
Csbo
Sold after exercise
7,100
$27.31
$193.88K
Harold Bernstein
1 Jul 2026
President, R&D & CMO
Sold after exercise
1,200
$30.34
$36.40K
Harold Bernstein
1 Jul 2026
President, R&D & CMO
Sold after exercise
13,409
$29.87
$400.46K
Atul Dandekar
29 Jun 2026
Csbo
Sold after exercise
7,500
$28.02
$210.15K
Harold Bernstein
1 Jun 2026
President, R&D & CMO
Sold after exercise
1,600
$26.36
$42.17K
Harold Bernstein
1 Jun 2026
President, R&D & CMO
Sold after exercise
13,253
$25.57
$338.94K
Atul Dandekar
29 May 2026
Csbo
Sold after exercise
7,500
$26.34
$197.55K
Harold Bernstein
14 May 2026
President, R&D & CMO
Sold after exercise
15,000
$26.22
$393.35K
Atul Dandekar
29 Apr 2026
Csbo
Sold after exercise
7,500
$25.37
$190.30K
Amy Bachrodt
1 Apr 2026
SVP, Finance
Sold after exercise
300
$30.34
$9.10K
Amy Bachrodt
1 Apr 2026
SVP, Finance
Sold after exercise
2,200
$29.32
$64.51K
Harold Bernstein
1 Apr 2026
President, R&D & CMO
Sold after exercise
300
$31.07
$9.32K
Harold Bernstein
1 Apr 2026
President, R&D & CMO
Sold after exercise
3,348
$30.06
$100.64K
Harold Bernstein
1 Apr 2026
President, R&D & CMO
Sold after exercise
11,352
$29.24
$331.95K
Atul Dandekar
30 Mar 2026
Csbo
Sold after exercise
790
$30.02
$23.71K
Atul Dandekar
30 Mar 2026
Csbo
Sold after exercise
6,710
$29.26
$196.31K
Harold Bernstein
20 Mar 2026
President, R&D & CMO
Sold after exercise
5,044
$50.02
$252.29K
Harold Bernstein
20 Mar 2026
President, R&D & CMO
Sold after exercise
3,795
$49.32
$187.17K
Harold Bernstein
20 Mar 2026
President, R&D & CMO
Sold after exercise
6,161
$48.20
$296.98K
Harold Bernstein
10 Mar 2026
President, R&D & CMO
Sold after exercise
348
$51.02
$17.75K
Harold Bernstein
10 Mar 2026
President, R&D & CMO
Sold after exercise
29,652
$50.45
$1.50M
Amy Bachrodt
2 Mar 2026
SVP, Finance
Sold after exercise
3,700
$45.47
$168.24K
Amy Bachrodt
2 Mar 2026
SVP, Finance
Sold after exercise
1,300
$44.44
$57.77K
Atul Dandekar
27 Feb 2026
Csbo
Sold after exercise
3,761
$45.72
$171.97K
Atul Dandekar
27 Feb 2026
Csbo
Sold after exercise
3,739
$45.13
$168.76K
Amy Bachrodt
2 Feb 2026
SVP, Finance
Sold after exercise
736
$46.63
$34.32K
Amy Bachrodt
2 Feb 2026
SVP, Finance
Sold after exercise
4,064
$46.03
$187.07K
Amy Bachrodt
2 Feb 2026
SVP, Finance
Sold after exercise
200
$44.15
$8.83K
Harold Bernstein
2 Feb 2026
President, R&D & CMO
Sold after exercise
100
$47.23
$4.72K
Harold Bernstein
2 Feb 2026
President, R&D & CMO
Sold after exercise
5,936
$46.37
$275.27K
Harold Bernstein
2 Feb 2026
President, R&D & CMO
Sold after exercise
8,364
$45.89
$383.82K
Harold Bernstein
2 Feb 2026
President, R&D & CMO
Sold after exercise
600
$44.21
$26.52K
Atul Dandekar
29 Jan 2026
Csbo
Sold after exercise
2,800
$45.01
$126.02K
Atul Dandekar
29 Jan 2026
Csbo
Sold after exercise
3,500
$44.04
$154.15K
Atul Dandekar
29 Jan 2026
Csbo
Sold after exercise
1,200
$43.18
$51.82K
Amy Bachrodt
22 Jan 2026
SVP, Finance
Sold after exercise
5,000
$45.52
$227.61K
Catherine A. Sohn
7 Jan 2026
Director
Sold after exercise
26,920
$39.11
$1.05M
Harold Bernstein
7 Jan 2026
President, R&D & CMO
Sold after exercise
25,156
$40.20
$1.01M
Catherine A. Sohn
6 Jan 2026
Director
Sold after exercise
2,493
$38.62
$96.27K
Harold Bernstein
5 Jan 2026
President, R&D & CMO
Sold after exercise
412
$40.00
$16.48K
Amy Bachrodt
2 Jan 2026
SVP, Finance
Sold after exercise
2,595
$39.57
$102.68K
Amy Bachrodt
2 Jan 2026
SVP, Finance
Sold after exercise
2,405
$38.70
$93.07K
Harold Bernstein
2 Jan 2026
President, R&D & CMO
Sold after exercise
4,432
$40.43
$179.19K
Amy Bachrodt
30 Dec 2025
SVP, Finance
Sold after exercise
5,000
$40.08
$200.41K
Atul Dandekar
30 Dec 2025
Csbo
Sold after exercise
100
$40.36
$4.04K
Amy Bachrodt
29 Dec 2025
SVP, Finance
Sold after exercise
600
$41.16
$24.69K
Amy Bachrodt
29 Dec 2025
SVP, Finance
Sold after exercise
9,400
$40.54
$381.07K
Harold Bernstein
29 Dec 2025
President, R&D & CMO
Sold after exercise
17,200
$40.93
$703.93K
Harold Bernstein
29 Dec 2025
President, R&D & CMO
Sold after exercise
27,800
$40.34
$1.12M
Atul Dandekar
29 Dec 2025
Csbo
Sold after exercise
6,035
$41.13
$248.21K
Atul Dandekar
29 Dec 2025
Csbo
Sold after exercise
66,365
$40.51
$2.69M
Show all 102 transactions →

What was left out

Form 4 filings counted 63
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 24
Sales straight out of an exercise 60
Sales at will 16
Transactions with no price 0
Shares from compensation/vesting 574,015
History held since 4 Feb 2025